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NEWS AND PERSPECTIVES
Since it was first reported in the 1960s, methicillin-
resistant Staphylococcus aureus (MRSA) has been a
major cause of a variety of infectious syndromes
in patients exposed to the healthcare environ-
ment.1 In Taiwan, MRSA was first documented 
in the early 1980s and increased rapidly in the
1990s.1 Nowadays, MRSA is endemic in most hos-
pitals in Taiwan and accounts for 53–83% of all
S. aureus isolates.1 However, from the late 1990s,
community-associated (CA) MRSA has become 
a major concern worldwide.2 CA-MRSA causes a
variety of diseases, ranging from skin or soft tissue
infection to severe invasive diseases, such as sepsis,
necrotizing pneumonia, and necrotizing fasci-
itis.1,2 CA-MRSA strains worldwide are thought to
have unique microbiological characteristics such
as limited antibiotic resistance (except to β-lactam
antimicrobial agents), different exotoxin gene
profiles (e.g. Panton–Valentine leukocidin; PVL),
and smaller staphylococcal cassette chromosome
mec (SCCmec) variants: either SCCmec type IV, or
less frequently, type V or a variant, type VT.3
In Taiwan, CA-MRSA infections have been re-
ported increasingly in pediatric patients since
2002. The rate of MRSA was estimated as 44% in
pediatric cases of CA S. aureus infections, after pool-
ing the data from retrospective studies with simi-
lar designs between 1997 and 2001.1 Currently,
the CA-MRSA strains that cause infection in
Taiwan are characterized by multiple antibiotic
resistance (including clindamycin, erythromycin,
tetracycline and chloramphenicol), which differs
from those in the United States,4 with skin and
superficial soft tissue infections being the major
clinical manifestations. However, significant 
morbidity and mortality from CA-MRSA infec-
tions have been reported increasingly in pedi-
atric cases.1,5 They have common pulsed-field gel
electrophoresis (PFGE) patterns that differ from
those of the major pandemic clones of hospital-
acquired MRSA isolates. Also, the genotype has
been identified as sequence type (ST) 59 by multi-
locus sequencing typing; they possess PVL and
staphylococcal enterotoxin B and may have ac-
quired SCCmec type VT (now designated type VII),
or less frequently, type IV.4,6,7
The importance of antibiotic stewardship for
CA-MRSA disease in Taiwan can be demon-
strated in four different ways. Several previous
community-based studies and the latest island-
wide survey have assessed the extent of MRSA in
the community, and have revealed a high preva-
lence of colonization with multidrug-resistant
MRSA.3,6,8 Compared with that among healthy
children during the period 2001–2002, the preva-
lence of nasal MRSA colonization among healthy
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children in Taiwan has increased significantly,
from 1.9% in 2001 to 9.5% in 2005–2006 for
Northern Taiwan and from 3.3% to 6.7% for
Southern Taiwan.8 This increasing trend in preva-
lence of community MRSA colonization might
account for the emergence of CA-MRSA disease
in Taiwan. Additionally, the high level of multi-
drug resistance among CA-MRSA strains, in asso-
ciation with the previously reported excessive use
of antibiotics in Taiwan, highlights the problem
of antibiotic selective pressure.9
The second aspect concerns the relationship
between nasal strains of PVL-positive MRSA and
CA disease, evidence of which has been provided
by antimicrobial drug susceptibility testing,
SCCmec typing, exotoxin profiling, and PFGE
typing.6 Our recently published prospective obser-
vational study has disclosed that previous anti-
biotic use is associated with PVL-positive MRSA
colonization.10 Therefore, appropriate use of anti-
microbial drugs might be a strategy for limiting
the incidence of CA-MRSA disease in Taiwan.
The third aspect is related to the novel molec-
ular characteristics of ST59 CA-MRSA strains in
Taiwan. Takano et al7 have shown that the major
PVL-positive CA-MRSA ST59Taiwan strain possesses
a tetracycline-resistance-conferring (tetK positive)
penicillinase plasmid and a multidrug-resistance
gene cluster (a possible composite transposon),
which imply indirectly the high antibiotic selec-
tive pressure in our community.
Finally, from the management point of view,
most authorities recommend that the therapeutic
strategy for CA-MRSA infections should be based
on the severity and site of disease in areas with
high prevalence of methicillin resistance, such 
as Taiwan.1,4 CA-MRSA infection is most often
manifested in the skin and superficial soft tissue
and responds well spontaneously or after inci-
sion and drainage, with or without susceptible
antibiotic treatment. Thus, the use of glycopep-
tides or linezolid should be reserved for patients
with invasive CA-MRSA infections or those that
involve deep-seated areas of the body, to limit the
impact of increasing antimicrobial resistance.
In the past, the rapid emergence of resistant
bacteria in Taiwan has been spurred on by the ease
of obtaining antibiotics from over-the-counter
drug stores, as well as the widespread use of anti-
microbial agents in animal husbandry. In 2001,
government policy prohibited antibiotic use for
acute respiratory tract infections without evidence
of bacterial infection, which resulted in a decrease
in the use of penicillins, cephalosporins and
macrolides, and also reduced macrolide-resistant
group A streptococci.11 Thus, an effective strategy
for antibiotic stewardship must be multifaceted
and include education of physicians and patients
about appropriate antimicrobial use, surveillance
of antimicrobial resistance and use, and develop-
ment of alternative treatment that circumvents
the need for antimicrobial therapy. In addition,
Schneider-Lindner et al12 have reported recently
an association between receipt of antimicrobial
agents and diagnosis of CA-MRSA in the United
Kingdom, which is particularly strong for previ-
ous exposure to fluoroquinolones and macrolides.
Further studies are warranted to elucidate the spe-
cific antimicrobial drugs that may cause selection
pressures that favor the acquisition of antibiotic
resistance in S. aureus in the community, to limit
the spread of CA-MRSA in Taiwan.
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